Clinical Trials

21 enrolled

Multiple Myeloma

NCT04877275 2023-12-06

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Multiple Myeloma

NCT04888741 2023-09-28

MoTD

LymphoidMyeloidOther hematologic neoplasmPlasma cell

400 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT03695744 2023-07-10

Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma

27 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04814615 2023-06-27

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

60 enrolled

Multiple Myeloma

NCT03809780 2023-06-22

LENDER

70 enrolled

Multiple Myeloma

NCT03641456 2023-06-18

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Neoplasms, Plasma Cell

NCT04941937 2023-02-27

Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMM

90 enrolled

Multiple Myeloma

NCT05712083 2023-02-21

A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma

40 enrolled

Multiple Myeloma

NCT05432414 2023-01-31

PVd Versus Vd in NDMM Patients With RI

79 enrolled

Multiple Myeloma

NCT03252600 2023-01-25

Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

53 enrolled

Immunoglobulin Light-chain Amyloidosis

NCT04277845 2022-09-09

KMM1910

49 enrolled

Multiple Myeloma

NCT03336073 2022-09-07

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

199 enrolled

Multiple Myeloma

NCT05509374 2022-08-22

KMM2002

33 enrolled

Multiple Myeloma

NCT05509530 2022-08-22

Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)

Multiple Myeloma

NCT05497102 2022-08-12

KMM1911

58 enrolled

Multiple Myeloma

NCT03570983 2022-06-22

BEAM

Multiple Myeloma

NCT04474938 2022-05-10

Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

40 enrolled

Immunoglobulin Light-chain Amyloidosis

NCT05147493 2022-03-29

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

51 enrolled

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

108 enrolled

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT05114109 2021-11-09

ICE

21 enrolled

Cryoglobulinemia, Familial Mixed, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT03669445 2020-07-30

IFM2018-01

45 enrolled

Multiple Myeloma

NCT03977103 2020-01-13

Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT

LymphoidMyeloidOther hematologic neoplasmPlasma cell

80 enrolled

Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04162119 2019-11-18

Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Plasmacytoma, Neoplasms, Plasma Cell

NCT04065308 2019-08-22

Dara_DCEP

33 enrolled

Plasmacytoma

NCT03757221 2019-07-08

IDARA

70 enrolled

Multiple Myeloma

NCT03992170 2019-06-20

DART4MM

Multiple Myeloma

NCT03931421 2019-06-04

B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma

Multiple Myeloma

NCT01240525 2019-02-12

ProT4

LymphoidMyeloidOther hematologic neoplasmPlasma cell

114 enrolled

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile

NCT03697655 2019-01-03

PREDATOR

274 enrolled

Multiple Myeloma

NCT03746652 2018-11-23

DARIA

Multiple Myeloma

NCT03601624 2018-11-14

MM-POM-2018

18 enrolled

Multiple Myeloma, Recurrence, Disease Progression

NCT02572492 2018-08-17

CARFI

200 enrolled

Multiple Myeloma, Recurrence

NCT03605056 2018-07-30

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

25 enrolled

Multiple Myeloma

NCT03143036 2018-06-07

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Recurrence, Neoplasms, Plasma Cell

NCT02158702 2018-05-17

Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

Multiple Myeloma

NCT03475628 2018-03-23

REBUILD

57 enrolled

Multiple Myeloma

NCT02086942 2017-08-29

Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.

94 enrolled

Multiple Myeloma

NCT03244930 2017-08-10

Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation

20 enrolled

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

NCT02967276 2017-05-02

METDEXA-MM

28 enrolled

Multiple Myeloma

NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

LymphoidOther hematologic neoplasmPlasma cell

24 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02624440 2015-12-08

SUTRICA

300 enrolled

Infections, Multiple Myeloma

NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00389701 2014-01-10

Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00003163 2014-01-06

Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

LymphoidOther hematologic neoplasmPlasma cell

10 enrolled

Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00004903 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00008307 2014-01-06

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

52 enrolled

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT02027220 2014-01-06

Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma

60 enrolled

Neoplasms, Plasma Cell

NCT00008164 2013-12-18

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia